En Route to IPO, San Diego’s Prometheus Labs Detours to Nestlé Buyout

San Diego’s , a specialty pharma and diagnostics company in registration for an IPO, has instead agreed to a buyout offer from Nestlé Health Science, a new subsidiary of Switzerland’s Nestlé S.A.
Xconomy